72 related articles for article (PubMed ID: 9269693)
41. Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease.
Aytaç MB; Deveci M; Bek K; Kayabey Ö; Ekinci Z
Pediatr Nephrol; 2016 Feb; 31(2):267-77. PubMed ID: 26432706
[TBL] [Abstract][Full Text] [Related]
42. Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study.
Lineen JR; Kuliszewski M; Dacouris N; Liao C; Rudenko D; Deva DP; Goldstein M; Leong-Poi H; Wald R; Yan AT; Yuen DA
Can J Kidney Health Dis; 2015; 2():25. PubMed ID: 26229686
[TBL] [Abstract][Full Text] [Related]
43. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
[TBL] [Abstract][Full Text] [Related]
44. Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study.
Ari E; Kaya Y; Demir H; Asicioglu E; Eren Z; Celik E; Arikan H
Int Urol Nephrol; 2014 Sep; 46(9):1843-9. PubMed ID: 24811568
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study.
Hamed EA; El-Abaseri TB; Mohamed AO; Ahmed AR; El-Metwally TH
BMC Nephrol; 2012 Oct; 13():136. PubMed ID: 23061474
[TBL] [Abstract][Full Text] [Related]
46. NFκB in the development of endothelial activation and damage in uremia: an in vitro approach.
Caballo C; Palomo M; Cases A; Galán AM; Molina P; Vera M; Bosch X; Escolar G; Diaz-Ricart M
PLoS One; 2012; 7(8):e43374. PubMed ID: 22937042
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity.
Lilitkarntakul P; Dhaun N; Melville V; Kerr D; Webb DJ; Goddard J
Diabetes Care; 2012 Aug; 35(8):1774-80. PubMed ID: 22648437
[TBL] [Abstract][Full Text] [Related]
48. Serum cadmium levels are independently associated with endothelial function in hemodialysis patients.
Kaya Y; Ari E; Demir H; Gecit I; Beytur A; Kaspar C
Int Urol Nephrol; 2012 Oct; 44(5):1487-92. PubMed ID: 21904850
[TBL] [Abstract][Full Text] [Related]
49. Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension.
Dubin R; Owens C; Gasper W; Ganz P; Johansen K
Hemodial Int; 2011 Jul; 15(3):350-8. PubMed ID: 21658174
[TBL] [Abstract][Full Text] [Related]
50. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease.
Owens CD; Wake N; Kim JM; Hentschel D; Conte MS; Schanzer A
J Vasc Access; 2010; 11(4):329-34. PubMed ID: 21038305
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular risk in the peritoneal dialysis patient.
Krediet RT; Balafa O
Nat Rev Nephrol; 2010 Aug; 6(8):451-60. PubMed ID: 20567248
[TBL] [Abstract][Full Text] [Related]
52. Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease.
Alqaisi F; Albadarin F; Jaffery Z; Tzogias L; Dawod M; Jacobsen G; Ananthasubramaniam K
J Nucl Cardiol; 2008; 15(6):754-61. PubMed ID: 18984450
[TBL] [Abstract][Full Text] [Related]
53. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease.
Wilson AC; Urbina E; Witt SA; Glascock BJ; Kimball TR; Mitsnefes M
Pediatr Nephrol; 2008 Aug; 23(8):1297-302. PubMed ID: 18458956
[TBL] [Abstract][Full Text] [Related]
54. [Atherosclerosis and uremia: signifance of non-traditional risk factors].
Hörl WH
Wien Klin Wochenschr; 2003 Apr; 115(7-8):220-34. PubMed ID: 12778774
[TBL] [Abstract][Full Text] [Related]
55. Homocysteine and blood pressure.
van Guldener C; Nanayakkara PW; Stehouwer CD
Curr Hypertens Rep; 2003 Feb; 5(1):26-31. PubMed ID: 12530932
[TBL] [Abstract][Full Text] [Related]
56. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
Stehouwer DA
Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
[TBL] [Abstract][Full Text] [Related]
57. Abnormalities of endothelial function in patients with predialysis renal failure.
Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN
Heart; 2000 Feb; 83(2):205-9. PubMed ID: 10648498
[TBL] [Abstract][Full Text] [Related]
58. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients.
van Guldener C; Lambert J; Janssen MJ; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 1997; 12 Suppl 2():14-8. PubMed ID: 9269693
[TBL] [Abstract][Full Text] [Related]
59. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480
[TBL] [Abstract][Full Text] [Related]
60. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients.
van Guldener C; Janssen MJ; Lambert J; Steyn M; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 1998 Jul; 13(7):1782-6. PubMed ID: 9681728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
